Abbott Laboratories

ABT | NYSE | 48 Followers

$133.55

-0.29%

-$0.39

Overview Metrics Financials

Fair Price

$776.42

Overvalued by 36.5%

To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Abbott Laboratories (ABT) is an American healthcare company with a global presence. The company specializes in the development, manufacturing, and distribution of a wide range of healthcare products and medications. Abbott focuses on innovative pharmaceuticals, diagnostic equipment, medical devices, and nutritional products. Their portfolio includes products for various areas of healthcare, such as cardiovascular care, diabetes care, gastroenterology, infectious disease diagnostics, maternal and pediatric care, and many others. The company has a long history and is known for its quality, reliability, and research in healthcare innovations. Abbott Laboratories plays a crucial role in improving people's health worldwide and collaborates with physicians and healthcare professionals on the development of medications and diagnostic solutions. Abbott Laboratories (ABT) shares are an interesting choice for investors who follow the healthcare sector and seek investment opportunities in a key company operating in the healthcare industry.

Feed

This $ABT stock news is available only to Bulios Black members.

Upgrade

ABT

$133.55

Abbott Laboratories

-0.29%

This $ABT stock news is available only to Bulios Black members.

Upgrade

ABT

$133.55

Abbott Laboratories

-0.29%

10M

This $ABT stock news is available only to Bulios Black members.

Upgrade

ABT

$133.55

Abbott Laboratories

-0.29%

10M

This $ABT stock news is available only to Bulios Black members.

Upgrade

ABT

$133.55

Abbott Laboratories

-0.29%

10M

Halil Toprak

@haliltoprak

Abbott Laboratories, güçlü tıbbi cihaz satışları sayesinde çeyreklik kârıyla beklentileri aştı.

Glikoz izleme ürünlerinin satışları özellikle güçlüydü.

Tıbbi müdahalelere yönelik talepteki artış genel büyümeyi destekledi.

Hisse başına 98 sentlik yıllık kazanç, analistlerin tahminlerini 3 sent aştı.

Abbott Laboratories $ABT, tüm yıl tahminini hisse başına 4,55 ila 4,70 dolara...
Read more

Çetin Tilki

@cetintilki

📈 Sağlık Hizmetlerinde Yatırım Mücevherleri 📈

Merhaba BuliosiansBugün burada sağlık sektörünün üç kralı var! 💰

Johnson & Johnson $JNJ
62 yılıaşkın tutarlı temettüleri ve AAA kredi notu ileJNJ ilginç bir seçimdir. Şirket ilaç, tıbbi cihaz ve teknolojiye odaklanarak tutarlılık ve dayanıklılığa vurgu yapıyor. Tarihsel olarak düşük ileri F/K (15) ve %3 temettü verimi ile bu şirket...
Read more

Çetin Tilki

@cetintilki

İyi ki Abbot'u 100 dolara almışım. Sonuçlar, yılın geri kalanında covid ürünlerinden elde edilen satışlara ilişkin beklentilerin düşmesine rağmen ideal.

Abbott Laboratories

Fair Price

Profile

Feed

Log in to Bulios

Create Bulios profile

Why Bulios?